APA (7th ed.) Citation

OC, E., P, B., S, B., N, O., B, S., C, S., . . . NV, A. (2024). Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols. Annals of surgical oncology, 31(10), 7001. https://doi.org/10.1245/s10434-024-15632-y

Chicago Style (17th ed.) Citation

OC, Eren, et al. "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols." Annals of Surgical Oncology 31, no. 10 (2024): 7001. https://doi.org/10.1245/s10434-024-15632-y.

MLA (9th ed.) Citation

OC, Eren, et al. "Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols." Annals of Surgical Oncology, vol. 31, no. 10, 2024, p. 7001, https://doi.org/10.1245/s10434-024-15632-y.